Epinephrine
Moderate or Severe Submental Fullness
Kythera BiopharmaceuticalsSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Moderate or Severe Submental Fullness cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Deoxycholic Acid Kythera Biopharmaceuticals | Phase 3 | BBB |
Loratadine Kythera Biopharmaceuticals | Phase 3 | BB |
LIDOCAINE Kythera Biopharmaceuticals | Phase 3 | BB |
IBUPROFEN Kythera Biopharmaceuticals | Phase 3 | BB |
Polyene Phosphatidylcholine AMIpharm Co., Ltd. | Phase 2 | B |
HY-2003 Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 | CC |
Same molecule, other indications
Epinephrine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →